Cytotoxic CD8+ T-cells are linked to improved outcomes in bladder cancer and are crucial for the effectiveness of IO therapies like anti-PD-1/PD-L1, though they can become exhausted. This evidence concerns the gene CD274 and urinary bladder carcinoma.